Cardiac Guidance vs FFRangio System
AI Verdict
Choose Cardiac Guidance if…
Choose Cardiac Guidance if your primary objective is to democratize access to diagnostic-quality cardiac ultrasound at the point of care, enabling non-expert ultrasound users to acquire and interpret critical cardiac assessments. This tool is ideal for settings like emergency medicine or primary care where early disease detection and rapid triage are paramount, leveraging AI guidance for consistent image acquisition and automated EF calculation.
View Cardiac Guidance →Choose FFRangio System if…
Choose the FFRangio System if you require advanced, wire-free, and drug-free 3D FFR guidance to optimize and confirm percutaneous coronary intervention (PCI) decisions for patients with coronary artery disease. This system is best suited for interventional cardiologists in the cath lab who need real-time FFR values, simulated pullback curves, and lesion impact assessments to precisely plan and evaluate stent placement without the need for invasive pressure wires.
View FFRangio System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Cardiac Guidance | FFRangio System |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing information. |
| Deployment | Caption Guidance is deployed in acute point-of-care settings, including emergency and anesthesiology departments and critical care units. It is also used in doctors' offices and can be used for at-home care. | SaaS, on-prem, hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Cardiac GuidanceTool A, Cardiac Guidance, is specifically designed to enable non-expert ultrasound users to acquire diagnostic-quality cardiac images through real-time AI guidance, turn-by-turn instructions, and automated quality assessment. This focus on democratizing access and simplifying a complex procedure for a broader audience indicates a higher degree of inherent usability.
Clinical Value
FFRangio SystemTool B, FFRangio System, offers a transformative clinical advancement by providing wire-free and drug-free 3D FFR guidance, effectively replacing an invasive procedure with a non-invasive, AI-driven alternative. This not only maintains high diagnostic accuracy but also significantly reduces patient risk, discomfort, and resource utilization, leading to improved patient outcomes and procedural efficiency.
Pricing & Value
FFRangio SystemTool B, FFRangio System, provides clear evidence of cost-effectiveness, with its procedure costing approximately $800, which is about half the cost of the traditional invasive method. Studies further demonstrate significant reductions in overall costs and cath lab resource utilization compared to invasive wire-based FFR. While Tool A has secured CMS NTAP status, a direct comparative cost for its core software for institutional use is not as explicitly detailed.
Enterprise Readiness
TieBoth tools demonstrate strong enterprise readiness. Tool A explicitly states HIPAA compliance and BAA availability, and its acquisition by GE HealthCare enhances its integration potential. Tool B has FDA clearance, ISO 27001 certification, and its acquisition by Medtronic similarly validates its readiness and integration capabilities within a major medical device ecosystem.
Innovation
FFRangio SystemTool B, FFRangio System, represents a more profound innovation by fundamentally changing how a critical cardiac assessment is performed, replacing an invasive procedure with a non-invasive, AI-driven method. While Tool A innovates in democratizing an existing diagnostic, Tool B introduces a paradigm shift in patient care by eliminating the need for invasive pressure wires and drugs.
Support & Docs
TieBoth tools appear to offer comprehensive support and documentation. Tool A provides online support and various training formats, with manuals accessible directly from the software. Tool B offers an Instructions For Use (IFU), a rich video library with expert insights, and patient education materials. Without more granular comparative data on the quality or responsiveness of support, it is difficult to distinguish a clear winner.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Cardiac Guidance | FFRangio System |
|---|---|---|
| Name | Cardiac Guidance | FFRangio System |
| Company | Caption Health | CathWorks |
| Description | FDA-cleared AI tool that empowers healthcare professionals to acquire and interpret diagnostic-quality cardiac ultrasound images at the point of care, democratizing access to critical cardiac assessments. | Delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease. |
| Primary Function | AI-guided cardiac ultrasound image acquisition and interpretation | Wire-free and drug-free 3D FFR guidance for PCI decisions |
| Key Features (Examples) | Real-time AI guidance for cardiac ultrasound image acquisition, Automated left ventricular ejection fraction (EF) calculation (Caption Interpretation) | Real-time FFRangio values at every point on the coronary tree, Eliminates the need for invasive pressure wires, drugs, or a guide catheter |
Videos
Demos, reviews, and walkthroughs featuring Cardiac Guidance and FFRangio System.